St. Michaels Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Stroke2 trials
• Coronary artery disease1 trial
• Metastatic breast cancer1 trial
• Peripheral artery disease1 trial

Phase

• Phase 33 trials
• Phase 2/31 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Joseph Broderick, MD2 trials
• CSL Behring1 trial
• Pfizer1 trial
• Western University, Canada1 trial

Running trials

• Recruiting

  Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

  NCT07227246· Phase 3· Joseph Broderick, MD· Source

  Contact: Alexandra Muccilli, MD

• Recruiting

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· Phase 2/3· CSL Behring· Source

  Contact: Trial Registration Coordinator

• Active, not recruiting

  PRevEnting FracturEs in REnal Disease - 1

  NCT05096195· Phase 4· Western University, Canada· Source

• Active, not recruiting

  Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial

  NCT03496883· Phase 3· Joseph Broderick, MD· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Coronary artery disease1 recruiting
• Peripheral artery disease1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

  NCT01740427· Phase 3· Pfizer· Source